Analysis on the Use of Hypoglycemic Drug in T2DM with High ASCVD Risk in 22 Hospitals in Beijing

Analysis on the Use of Hypoglycemic Drug in T2DM with High ASCVD Risk in 22 Hospitals in Beijing

Liao Yin, Cui Xiangli, Zhen Jiancun, Wang Wenfeng, Li Dandan, Chen Ning, Chen Zhengkai, Xia Doudou, Yan Bing

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (1) : 96-101.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (1) : 96-101. DOI: 10.16153/j.1002-7777.2023.01.011

Hospital Pharmaceutical Affairs

Analysis on the Use of Hypoglycemic Drug in T2DM with High ASCVD Risk in 22 Hospitals in Beijing

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(1): 96-101 https://doi.org/10.16153/j.1002-7777.2023.01.011

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉